tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

IMMP Stock Latest News

Immutep announces new data from EFTISARC-NEO
The FlyImmutep announces new data from EFTISARC-NEO
2d ago
IMMP
Immutep’s Efti Shows Promise in Cancer Therapy
PremiumCompany Announcements
Immutep’s Efti Shows Promise in Cancer Therapy
3d ago
6K
IMMP
Immutep announces efficacy, safety results from TACTI-003 Phase IIb trial
PremiumThe Fly
Immutep announces efficacy, safety results from TACTI-003 Phase IIb trial
4d ago
IMMP
Immutep’s Efti in Combination with MSD’s KEYTRUDA® Leads to Positive Efficacy with Favourable Safety in First Line Head and Neck Cancer
PremiumPress Releases
Immutep’s Efti in Combination with MSD’s KEYTRUDA® Leads to Positive Efficacy with Favourable Safety in First Line Head and Neck Cancer
4d ago
IMMP
Immutep: Quarterly Rebalance of S&P/ASX Indices
PremiumCompany Announcements
Immutep: Quarterly Rebalance of S&P/ASX Indices
10d ago
6K
IMMP
Immutep Reports Increased Loss Despite Higher Income
PremiumCompany AnnouncementsImmutep Reports Increased Loss Despite Higher Income
17d ago
6K
IMMP
Immutep Launches Groundbreaking Autoimmune Therapy Trial
Premium
Company Announcements
Immutep Launches Groundbreaking Autoimmune Therapy Trial
1M ago
6K
IMMP
Immutep announces first participant dosed in Phase I study of IMP761
Premium
The Fly
Immutep announces first participant dosed in Phase I study of IMP761
1M ago
IMMP
Immutep Announces First Participant Dosed in Phase I Study of IMP761, a First in Class Agonist LAG-3 Antibody
PremiumPress Releases
Immutep Announces First Participant Dosed in Phase I Study of IMP761, a First in Class Agonist LAG-3 Antibody
1M ago
IMMP
Immutep Advances LAG-3 Immunotherapy Trials
PremiumCompany Announcements
Immutep Advances LAG-3 Immunotherapy Trials
2M ago
6K
IMMP
Immutep resports quarterly activities for Q4
PremiumThe Fly
Immutep resports quarterly activities for Q4
2M ago
IMMP
Immutep Quarterly Activities Report Q4 FY24
PremiumPress Releases
Immutep Quarterly Activities Report Q4 FY24
2M ago
IMMP
Immutep Advances Cancer Trial with FDA Approval
PremiumCompany AnnouncementsImmutep Advances Cancer Trial with FDA Approval
2M ago
6K
IMMP
Immutep Announces Successful Meeting with FDA on Phase III Design in Non-Small Cell Lung Cancer
Premium
Press Releases
Immutep Announces Successful Meeting with FDA on Phase III Design in Non-Small Cell Lung Cancer
2M ago
IMMP
Immutep announces meeting with FDA on Phase III design in NSCLC
Premium
The Fly
Immutep announces meeting with FDA on Phase III design in NSCLC
2M ago
IMMP
Immutep receives regulatory clearance for Phase I study of IMP761
PremiumThe Fly
Immutep receives regulatory clearance for Phase I study of IMP761
2M ago
IMMP
Immutep Reports Positive Results in First Line Head and Neck Squamous Cell Carcinoma Patients with Negative PD-L1 Expression
PremiumPress Releases
Immutep Reports Positive Results in First Line Head and Neck Squamous Cell Carcinoma Patients with Negative PD-L1 Expression
2M ago
IMMP
Immutep Announces Details for Oral Presentation at ESMO Virtual Plenary Session and Webcast to Discuss Clinical Results
PremiumPress Releases
Immutep Announces Details for Oral Presentation at ESMO Virtual Plenary Session and Webcast to Discuss Clinical Results
3M ago
IMMP
Immutep to present clinical data from TACTI-003 Phase IIb trial
PremiumThe Fly
Immutep to present clinical data from TACTI-003 Phase IIb trial
3M ago
IMMP
Immutep’s Promising Cancer Treatment Trial Results
PremiumCompany AnnouncementsImmutep’s Promising Cancer Treatment Trial Results
3M ago
6K
IMMP
Immutep price target lowered to $6 from $7 at Baird
Premium
The Fly
Immutep price target lowered to $6 from $7 at Baird
3M ago
IMMP
Immutep signs exclusive license agreement with Cardiff University
Premium
The Fly
Immutep signs exclusive license agreement with Cardiff University
3M ago
IMMP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >